High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers
Ling Zhang(Zhengzhou University), Hao Shen(Tongji University), Zhishun Wang(Central Hospital of Wuhan), Changgeng Xu(Huazhong University of Science and Technology), Yonglian Guo(Aerospace Center Hospital), Zhengshuai Song(Central Hospital of Wuhan)
Cited by 14
Related Papers
1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis
|Journal for ImmunoTherapy of Cancer|2018|79
Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo
|Journal of Experimental & Clinical Cancer Research|2015|66
Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13
|Cellular & Molecular Biology Letters|2019|59
Theaflavin ameliorates renal ischemia/reperfusion injury by activating the Nrf2 signalling pathway in vivo and in vitro
|Biomedicine & Pharmacotherapy|2020|59